During the past decade, Kansas Nephrology Research Institute, LLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas Nephrology Research Institute, LLC" #1 sponsor was "Bayer" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Fresenius Medical Care North America" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas Nephrology Research Institute, LLC" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Medical Nutrition USA, Inc." with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kansas Nephrology Research Institute, LLC" are "Diabetic Kidney Disease" (2 trials), "ADPKD" (1 trials), "Anemia of Chronic Kidney Disease" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Kansas Nephrology Research Institute, LLC" in a lesser frequency.

Most popular intervention types in "Kansas Nephrology Research Institute, LLC" are "Drug" (12 trials), "Biological" (2 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Epoetin Hospira" (2 trials), "Finerenone (BAY94-8862)" (2 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kansas Nephrology Research Institute, LLC" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Kansas Nephrology Research Institute, LLC". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Kansas Nephrology Research Institute, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kansas Nephrology Research Institute, LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".